Lead, Venous Confirmation by ICP-MS
| Label Mnemonic: | LEADV |
| Epic code: | LAB7479 |
| Downtime form: | Doctor/Provider Orders - Pathology Core and Specialty Care Nursery |
Commercial Mailout Laboratory
6240-8 RCP
356-8593
6240-8 RCP
356-8593
Specimen(s):
Whole Blood
Specimen
Instructions:
This test is for venous collection only. Capillary samples are NOT
acceptable. Refer to the link below for Lead, Blood, by LeadCare II.
Collection Medium:
![]() |
| Royal Blue K2 EDTA tube |
Minimum:
Preferred Minimum: 6 mL whole blood in royal blue K2 EDTA tube
Pediatric and Absolute Minimum: 0.5 mL whole blood in royal blue K2 EDTA top tube
Pediatric and Absolute Minimum: 0.5 mL whole blood in royal blue K2 EDTA top tube
Rejection Criteria:
Serum. Specimens collected in tubes other than Royal Blue (K2EDTA).
Heparinized or clotted specimens. Capillary pediatric EDTA collection
tubes, refer to Lead, Blood (Capillary).
Turn Around
Time:
1-3 days upon receipt at reference laboratory
Reference Range:
0.0-4.9 μg/dL
Concentration Comment
5-9.9 μg/dL Adverse health effects are possible, particularly
in children under 6 years of age and pregnant women.
Discuss health risks associated with continued lead
exposure. For children and women who are or may become
pregnant, reduce lead exposure.
All ages
10-19.9 μg/dL Reduced lead exposure and increased biological
monitoring are recommended.
All ages
20-69.9 μg/dL Removal from lead exposure and prompt medical
evaluation are recommended. Consider chelation therapy
when concentrations exceed 50 μg/dL and symptoms
of lead toxicity are present.
All ages
>44.9 μg/dL Critical. Immediate medical evaluation is
recommended. Consider chelation therapy when symptoms
of lead toxicity are present.
Less than 19 years of age
>69.9 μg/dL Critical. Immediate medical evaluation is
recommended. Consider chelation therapy when symptoms
of lead toxicity are present.
Greater than 19 years of age Interpretive Data:
Elevated results may be due to skin or collection-related
contamination, including the use of a noncertified lead-free tube. If
contamination concerns exist due to elevated levels of blood lead,
confirmation with a second specimen collected in a certified lead-free
tube is recommended.
Information sources for reference intervals and interpretive comments include the "CDC Response to the 2012 Advisory Committee on Childhood Lead Poisoning Prevention Report" and the "Recommendations for Medical Management of Adult Lead Exposure, Environmental Health Perspectives, 2007." Thresholds and time intervals for retesting, medical evaluation, and response vary by state and regulatory body. Contact your State Department of Health and/or applicable regulatory agency for specific guidance on medical management recommendations.
Information sources for reference intervals and interpretive comments include the "CDC Response to the 2012 Advisory Committee on Childhood Lead Poisoning Prevention Report" and the "Recommendations for Medical Management of Adult Lead Exposure, Environmental Health Perspectives, 2007." Thresholds and time intervals for retesting, medical evaluation, and response vary by state and regulatory body. Contact your State Department of Health and/or applicable regulatory agency for specific guidance on medical management recommendations.
Comments:
Expected turn-around time is 2-4 days. For acute poisoning cases
where fast turnaround time is important, order LEAD, BLOOD (BY
LEADCARE) (LAB98) for analysis of capillary specimens.
Methodology:
Quantitative Inductively Coupled Plasma/Mass Spectrometry
CPT Code:
83655
